We observed clear differential expression patterns between patients with congenital hemolytic anemia (thalassemia and SCD) and congenital anemia due to bone marrow failure (CSA with the SLC25A38 mutation) and then compared them to healthy controls [1]. This evidence concerns the gene SLC25A38 and Bone marrow hypocellularity.